Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Achilles Therapeutics ADR | ACHL | Nov 13, 2024 | 1.02 | +0.99 |
ACI Worldwide | ACIW | Nov 13, 2024 | 56.69 | -0.14 |
Aclarion | ACON | Nov 13, 2024 | 0.17 | -4.40 |
Aclaris Therapeutics | ACRS | Nov 13, 2024 | 2.44 | -4.69 |
ACM Research A | ACMR | Nov 13, 2024 | 18.59 | -0.43 |
Acme United | ACU | Nov 13, 2024 | 42.50 | +1.72 |
ACNB | ACNB | Nov 13, 2024 | 47.61 | -1.06 |
ACRES Commercial Realty | ACR | Nov 13, 2024 | 16.23 | -0.06 |
ACRES Commercial Realty C Pref | ACR-C | Nov 13, 2024 | 24.97 | -0.08 |
ACRES Commercial Realty D Pref | ACR-D | Nov 13, 2024 | 23.45 | +0.65 |
Acrivon Therapeutics | ACRV | Nov 13, 2024 | 7.93 | -5.48 |
Actelis Networks | ASNS | Nov 13, 2024 | 1.37 | -0.72 |
Actinium Pharmaceuticals | ATNM | Nov 13, 2024 | 1.71 | -5.00 |
Active Bear ETF | HDGE | Nov 13, 2024 | 17.37 | +0.15 |
Active U.S. Real Estate Powershares | PSR | Nov 13, 2024 | 95.66 | +0.35 |
Actuate Therapeutics | ACTU | Nov 13, 2024 | 8.56 | 0.00 |
Acuity Brands | AYI | Nov 13, 2024 | 330.70 | -0.36 |
Acumen Pharmaceuticals | ABOS | Nov 13, 2024 | 2.53 | -5.42 |
Acurx Pharmaceuticals | ACXP | Nov 13, 2024 | 1.82 | -1.62 |
Acushnet | GOLF | Nov 13, 2024 | 68.64 | -2.39 |
ACV Auctions A | ACVA | Nov 13, 2024 | 20.37 | -1.59 |
ACWI Ex-US Index MSCI Ishares | ACWX | Nov 13, 2024 | 53.48 | -0.59 |
ACWI Index MSCI Ishares | ACWI | Nov 13, 2024 | 120.31 | -0.20 |
Adagene ADR | ADAG | Nov 13, 2024 | 2.37 | -3.27 |
Adagio Medical | ADGM | Nov 13, 2024 | 2.35 | -2.08 |
Adams Diversified Equity Fund | ADX | Nov 13, 2024 | 22.45 | +0.09 |
Adams Natural Resources Fund | PEO | Nov 13, 2024 | 24.40 | +0.33 |
Adams Resources & Energy | AE | Nov 13, 2024 | 37.05 | 0.00 |
AdaptHealth | AHCO | Nov 13, 2024 | 10.60 | -0.84 |
Adaptimmune Therapeutics ADR | ADAP | Nov 13, 2024 | 0.77 | -2.91 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.